| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 8.58B | 8.61B | 8.30B | 6.87B | 6.05B | 5.70B |
| Gross Profit | 3.05B | 2.87B | 2.60B | 2.13B | 2.15B | 1.98B |
| EBITDA | 1.23B | 1.14B | 1.05B | 661.00M | 854.00M | 702.00M |
| Net Income | 716.00M | 477.00M | 437.00M | 275.00M | 472.00M | 265.00M |
Balance Sheet | ||||||
| Total Assets | 10.34B | 11.14B | 10.68B | 10.32B | 9.55B | 9.26B |
| Cash, Cash Equivalents and Short-Term Investments | 339.00M | 953.00M | 658.00M | 583.00M | 692.00M | 396.00M |
| Total Debt | 1.64B | 2.51B | 2.48B | 2.48B | 2.37B | 2.48B |
| Total Liabilities | 4.77B | 5.71B | 5.58B | 5.32B | 5.03B | 5.08B |
| Stockholders Equity | 5.57B | 5.43B | 5.10B | 4.99B | 4.51B | 4.18B |
Cash Flow | ||||||
| Free Cash Flow | 794.00M | 602.00M | 496.00M | 305.00M | 664.00M | 366.00M |
| Operating Cash Flow | 940.00M | 765.00M | 778.00M | 519.00M | 858.00M | 656.00M |
| Investing Cash Flow | -133.00M | -91.00M | -280.00M | -213.00M | -191.00M | -289.00M |
| Financing Cash Flow | -1.20B | -367.00M | -379.00M | -406.00M | -436.00M | -476.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | kr11.14B | 15.37 | 12.72% | 2.80% | 0.81% | 57.02% | |
71 Outperform | €4.89B | 14.95 | 9.65% | 5.13% | 3.79% | 39.15% | |
71 Outperform | kr3.14B | 18.39 | ― | 4.38% | 19.47% | 46.15% | |
68 Neutral | kr6.29B | 20.31 | ― | 2.62% | 7.37% | 2.90% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | €3.51B | 79.74 | 0.87% | ― | 5.99% | -38.16% | |
58 Neutral | €1.23B | ― | -0.17% | 2.40% | -2.95% | -112.90% |
Cloetta AB reported a strong increase in profitability for the July-September 2025 quarter, driven by strategic focus on margin enhancement and cost control, despite a slight decline in net sales. The company is on track to meet its mid-term EBIT margin target of 12% by 2027, with notable growth in its Pick & mix segment and improved operating profits.
The most recent analyst rating on ($SE:CLA.B) stock is a Buy with a SEK41.00 price target. To see the full list of analyst forecasts on Cloetta AB stock, see the SE:CLA.B Stock Forecast page.
Cloetta AB has announced the appointment of its Nomination Committee in preparation for the Annual General Meeting scheduled for April 2026. The committee, comprising members appointed by major stakeholders, will oversee the nomination process, reflecting Cloetta’s commitment to transparent governance and stakeholder engagement.
The most recent analyst rating on ($SE:CLA.B) stock is a Hold with a SEK34.00 price target. To see the full list of analyst forecasts on Cloetta AB stock, see the SE:CLA.B Stock Forecast page.